Scientific Programme


Mr Abel Ang
Group Chief Executive Officer,
Advance MedTech Holdings

Mr Abel Ang is the founding Group Chief Executive Officer of Advanced MedTech Holdings, a ~US$300M global player in urology devices and services. The group has quadrupled its revenue since its founding. Mr. Ang has a proven track record in the medical device sector. He has served as the Senior Advisor to the CEO of Greatbatch Inc (NYSE: ITGR), providing guidance relative to the commercialization of medical device technologies in the cardiac, neurology, vascular and orthopedic markets. Prior to Greatbatch, Mr. Ang was President, Asia/Pacific for Hill-Rom Inc. a US$3B revenue medical devices company (acquired by NYSE: BAX) where he was responsible for leading, developing and implementing the strategy to expand Hill-Rom’s presence in the Asia/Pacific markets. He formerly served as the Chief Technology Officer for Hill-Rom for 3 years. In that role he had overall responsibility for Hill-Rom’s global R&D operations which are distributed across sites in the U.S., Mexico, France, and Singapore. At Hill-Rom, he also held the positions of Vice-President and General Manager of Hill-Rom’s US$420M Global Therapy Business unit, and Vice-President for International Business Development. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board(EDB). Mr. Ang sits on the Board of Economic Development Innovations Singapore, a privately-held investment holding company headquartered in Singapore with direct investments in deeptech, education and listed assets. He sits on the Boards of the following Advanced MedTech group companies: Dornier MedTech GmbH, AMT Pte Ltd, and AbAsia Pte Ltd. In addition to the various Advanced MedTech portfolio companies, he chairs the Board of AWAK Technologies, which is developing a novel peritoneal dialysis device. He was formerly on the Board and Nominating Committee of Aslan Pharmaceuticals (NYSE: ASLN). Mr. Ang is an Adjunct full Professor at the Nanyang Business School in Singapore and Waseda University in Japan, where he teaches in their respective MBA programs. Mr. Ang has a Master of Science in Computational Biology from Rutgers University in New Jersey, which he pursued while on an EDB scholarship. He attended Harvard Business School’s Advanced Management Program in 2012. He was awarded the Public Service Medal (PBM) in 2021 for his contributions to the medical device industry in Singapore.

Programme Details

Day 1, 12 October 2022 , Wednesday, 1330 – 1500hrs
Session 3: 12 Oct 2022, Wed, 1330 - 1500hrs
Track : The Impact of Technology (Level 1, Hall 1, ApeX)
Topic : Panel Discussion: The Impact of Technology